Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 26

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 26
---
 Committee include:

| • | identifying and evaluating candidates, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, to serve on the Board; |

| • | considering and making recommendations to the Board regarding the composition and chairmanship of the committees of the Board; |

| • | overseeing succession planning for the Board and key leadership roles on the Board and its committees; |

| • | periodically reviewing and making recommendations to our Board’s regarding the leadership structure of the Board; |

| • | instituting plans or programs for the continuing education of our Board and orientation of new directors; |

| • | reviewing and making recommendations to our Board regarding environmental, social responsibility and sustainability matters; |

| • | evaluating developments in corporate governance and shareholder engagement and reviewing the Company’s governance documents, disclosures and other actions related thereto; |

| • | reviewing and making recommendations to our Board regarding corporate governance guidelines and matters; and |

| • | overseeing periodic evaluations of Board performance, including committees of the Board and management. |

The Nominating Committee is composed of three directors: Dr. Katabi, Dr. Morrissey, and Ms. Oliger. Dr. Cheng also served on the Nominating Committee until July 2024. All members of the Nominating Committee are independent (as independence is currently defined in Rule 5605(a)(2) of the Nasdaq listing rules). The Nominating Committee met one time during 2024. The Board has adopted a written Nominating Committee charter that is available to stockholders on the Company’s website at https://ir.veratx.com/corporate-governance/governance-highlights. The information on the Company’s website is not incorporated by reference into this Proxy Statement or the Annual Report. The Nominating Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The Nominating Committee also intends to consider such factors as possessing

16

TABLE OF CONTENTS relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of the Company’s stockholders. However, the Nominating Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the